CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) is consolidating its specialty pharmaceutical distribution, physician services and global logistics businesses under a single operating division, restructuring the company’s operations and financial reporting to give investors a clearer view of its specialty healthcare business.
The realignment places Richard Tremonte in charge of the new Specialty Pharmaceutical and Provider Services segment, bringing together businesses serving pharmaceutical manufacturers, healthcare providers and specialty medical practices.
Cencora will organize its remaining U.S. operations and European wholesale pharmaceutical distribution business under a second segment, Pharmaceutical Distribution and Services.
The restructuring marks a shift from the company’s previous geographic reporting model toward a structure that separates specialty pharmaceutical services from broader drug distribution operations.
The changes follow two years of investments intended to expand Cencora’s specialty healthcare capabilities, including services supporting physician practices, pharmaceutical commercialization and complex drug distribution.
“Our realigned organizational structure reflects our focus on ensuring Cencora is uniquely positioned as a leader in supporting pharmaceutical innovation,” President and Chief Executive Officer Robert P. Mauch said.
The specialty segment will combine distribution and group purchasing organization services supporting thousands of community-based specialists across the United States with oncology and retina physician management services organizations.
Those physician services businesses provide administrative support, clinical trial and research capabilities, and data analytics to medical practices.
The segment will also incorporate Cencora’s global specialty logistics network, which operates 140 logistics sites across more than 50 countries and supports clinical trials and the distribution of complex therapies.
Its multinational third-party logistics operations handle 23 million lines across 15 countries in North America and Europe.
Additional operations include pharmaceutical commercialization services in Canada and global services covering pharmacovigilance, regulatory affairs and market access.
Consolidating those businesses under Tremonte will place specialty distribution, physician support, logistics and commercialization activities within one management and reporting structure.
Cencora’s Pharmaceutical Distribution and Services segment will retain its broader wholesale distribution operations, with separate leadership for major customer groups.
Matthew Glucksmann will lead the Health Systems business, which serves hospitals, health systems and government facilities.
That operation includes wholesale and specialty pharmaceutical distribution, pharmacy support services, specialty group purchasing services and unit-dose repackaging.
Tim Cernohous will oversee Retail Pharmacy and Alternate Care, which provides pharmaceutical distribution services to community pharmacies and other healthcare settings.
Juan Guerra will lead the company’s European wholesale pharmaceutical distribution business.
The revised structure establishes separate management responsibilities for specialty pharmaceutical services, institutional healthcare customers, retail pharmacy distribution and European wholesale operations.
Cencora said the changes are intended to improve operational execution while making the financial performance of its principal businesses more transparent to shareholders.
“The updated reporting structure will also give our shareholders a clearer view of our progress against our strategic priorities and how we are creating sustainable, long-term value across our enterprise,” Mauch said.
To support comparisons under the revised reporting structure, Cencora is providing recast, unaudited segment financial information for fiscal 2025 and 2026 in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission.
The revised reporting framework will allow investors to evaluate the company’s specialty pharmaceutical and provider services operations separately from its traditional wholesale distribution businesses.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.
